Portland Indian Community - PortlandIndian.com
| | | | | | | | | | | |
 


 

Improving stroke treatment with modified therapeutic molecule

Canada,Health/Medicine

Author : Indo Asian News Service

International, Health/Medicine, National, Canada Read Latest News and Articles

Share With Your Friends



Add an Article

View All Contributions

Add To My Favorite

Add A Picture

Toronto, Feb 19 (IANS) A team of researchers has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain.

According to the team, a type of stroke -- also known as a "cerebral infarction" -- can lead to psychological and physical after-effects. These effects result from an increase in glutamate in the brain, which destroys neurons.

"Glutamate is an essential neurotransmitter for neuronal communication, learning and memory processes, yet above a certain concentration, it becomes toxic to neuronal cells," said researcher Ahlem Zaghmi from the Institut national de la recherche scientifique (INRS) in Canada.

For the study, published in the journal Communications, the research team aimed at developing an effective treatment that would compensate for the increase in glutamate.

"Unlike other drugs, our molecule does not need to cross the blood-brain barrier to achieve its therapeutic effect. It represents one fewer obstacle, since it could be injected intravenously," the researcher said.

The modified molecule, glutamate-oxaloacetate transaminase (GOT), is already known for its therapeutic effects. This enzyme breaks down the glutamate circulating in the bloodstream which creates a kind of siphon effect.

"By decreasing concentrations of this neurotransmitter in the blood, excess glutamate in the brain will move out to compensate for the loss. This "siphons" the glutamate out of the brain," she said.

A single dose of the molecule typically lasts three hours in rats. Due to the modification made by the research team, the treatment is now effective for six days.

The research team now intends to observe the longer-term effect of the molecule and explore applications to other neuronal diseases.

--IANS

vc/sdr/


Copyright and Disclaimer: All news and images appearing in our news section, search engines and social media are provided by IANS. If you face any issues related to the content/images, please contact our news service provider directly. We are not liable/responsible for any content/images related to the news service provider.


Latest News

View More News


More News Articles

Shahid Kapoor looks 'hard' in his 'aaj ka mood' from 'Deva' sets

Gurinder Chadha returns to big screen with Bollywood twist to Dickens' classic

Shakti Anand shot cart-pushing sequence in one take for 'Kundali Bhagya'

Harsh Chhaya aka Papaji is back to reclaim his power in 'Undekhi' Season 3

Junaid Khan wraps up his second untitled film after 58-day shoot